These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14416683)

  • 1. [Our experiences with the treatment of malignant lymphomas].
    LIBANSKY J; BRABEC V; CHUDOMEL V; SVOBODA M; SOCHMAN J
    Cas Lek Cesk; 1959 Oct; 98():1284-93. PubMed ID: 14416683
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigations in malignant lymphomas.
    RUNDLES RW; LUKES R; ACKERMAN L; HOLLAND J; SPEAR P; SCOTT JL; SPURR CL
    Natl Cancer Inst Monogr; 1960 Aug; 3():193-227. PubMed ID: 14440189
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy of the malignant lymphomas and leukemias.
    GAMBLE JF
    Med Ann Dist Columbia; 1962 Apr; 31():195-9. PubMed ID: 13896557
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of cancers and malignant lymphomas with massive chemotherapy and marrow transplant].
    MEZA ARRAU C; LARAIN C; OBERHAUSER E; ASALGADO N
    Sangre (Barc); 1962; 7():33-54. PubMed ID: 14473234
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of cancers and malignant lymphomas with massive chemotherapy and marrow transplants].
    MEZA C; LARRAIN C; OBERHAUSER E; ASALGADO N
    Rev Med Chil; 1962 Apr; 90():328-35. PubMed ID: 14473235
    [No Abstract]   [Full Text] [Related]  

  • 6. Uric acid excretion in patients with malignant lymphomas.
    PRIMIKIRIOS N; STUTZMAN L; SANDBERG AA
    Blood; 1961 Jun; 17():701-18. PubMed ID: 13738036
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiation therapy and adjunctive chemotherapy in the treatment of lymphomas.
    KRABBENHOFT KL
    Am J Roentgenol Radium Ther Nucl Med; 1960 Oct; 84():775-7. PubMed ID: 13753843
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects on the marrow of chemotherapy, used for the treatment of lymphomas and leukaemias.
    MADIGAN J; MOTTERAM R
    Acta Unio Int Contra Cancrum; 1959; 15(Suppl 1)():194-5. PubMed ID: 14419682
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical use of epoxypiperazine, a new alkylating agent, in the treatment of lymphomas and other neoplasms.
    MILLER DG; DIAMOND HD; CRAVER LF
    Cancer Res; 1959 Dec; 19():1204-9. PubMed ID: 14422486
    [No Abstract]   [Full Text] [Related]  

  • 10. [Outlines of medical cancerology. 2. Lymphomas. General plan for directing the treatment].
    SILVA MS
    Rev Bras Cir; 1960 May; 39():391-403. PubMed ID: 14446717
    [No Abstract]   [Full Text] [Related]  

  • 11. The chemotherapy of lymphomas.
    DIAMOND HD
    N Y State J Med; 1961 Mar; 61():871-8. PubMed ID: 13722602
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of uracil mustard in chronic lymphatic leukemia and malignant lymphoma.
    KENNEDY BJ; THEOLOGIDES A
    Cancer Chemother Rep; 1961 Apr; 11():77-80. PubMed ID: 13752495
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of Cyren-B as a leukocyte protecting agent in patients undergoing radiotherapy or chemotherapy for malignant lymphoma.
    WEBSTER JH; LESSMANN EM; SOKAL JE
    Acta radiol; 1961 Sep; 56():231-6. PubMed ID: 14040199
    [No Abstract]   [Full Text] [Related]  

  • 14. 1:2,3:4-Diepoxybutane in the treatment of Hodgkin's disease and lymphoreticulosarcoma.
    BICHEL J; STENDERUP A; JENSEN KB
    Acta Unio Int Contra Cancrum; 1960; 16():503-7. PubMed ID: 13848084
    [No Abstract]   [Full Text] [Related]  

  • 15. Malignant lymphoma and leukaemias.
    GALTON DA
    Cancer Prog; 1960; ():226-31. PubMed ID: 13703207
    [No Abstract]   [Full Text] [Related]  

  • 16. Uracil mustard, a new alkylating agent for oral administration in the management of patients with leukemia and lymphoma.
    KENNEDY BJ; THEOLOGIDES A
    N Engl J Med; 1961 Apr; 264():790-3. PubMed ID: 13752496
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preliminary experiences with Bayer DG-428 in the treatment of malignant neoplasms of the bladder in advanced stage].
    COZZI PA; PAIANI P
    Friuli Med; 1961; 16():77-84. PubMed ID: 13881930
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemicals most effective in malignant blood diseases.
    SAMPEY JR
    J S C Med Assoc; 1961 Apr; 57():163-4. PubMed ID: 13745959
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and haematological observations in lymphoma patients (Hodgkin's disease, Brill-Symmer's disease, lymphogenous leukaemia) treated with N N Di-2-chloroethyl gamma-P-aminophenyl butiric acid (amboclorin).
    PERRONE V; FAIELLA A; ZARRILLI D; CAJANO A
    Acta Unio Int Contra Cancrum; 1960; 16():907-9. PubMed ID: 14432002
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experiences with the cyclic nitrogen mustard phosphamide ester, Endoxan in the treatment of malignant tumors].
    SCHARENBERG P; KAPISCHKE F
    Munch Med Wochenschr; 1962 Jan; 104():134-8. PubMed ID: 14498052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.